You are on page 1of 16

Busqueda; buscadores web (27-01-2014)

1 alta vista; sin resultados ya que el computador me deriba a yahoo.es.


2Ask;
- http://www.ask.com/web?q=cpap+boussignac&search=&qsrc=0&o=0&l=dir&ad=dirN
1- Active humidification with Boussignac CPAP: in vitro study
of a new method.
Alonso-Iigo JM, Almela A, Albert A, Carratal JM, Fas MJ.
Author information
Abstract
OBJECTIVE:
To carry out an in vitro study of Boussignac CPAP valve performance with a new humidification
method, using a heated humidifier.
METHODS:
Two heated humidifiers were evaluated: Fisher & Paykel MR850, and Covidien Kendall Aerodyne
2000. Baseline measurements were taken in all experimental conditions without humidification. The
Boussignac valve was adapted to the input of the humidification chamber. The system was
connected to a test lung to assess the degree of pressurization. Hygrometric and pressure
measurements were performed with the following gas flows: 10, 20, 30 and 40 L/min.
RESULTS:
The mean values of pressure generated by the Boussignac valve were 1.99 0.02, 6.97 0.05,
16.61 0.08 and 21.24 0.08 cm H2O, 10, 20, 30 and 40 L/min, respectively, no differences being
detected between study groups. Overall absolute humidity was significantly greater with a heated
humidifier than without humidification (range 40.01 0.57-25.46 0.49 compared to 0.16 0.13
mgH2O/L, P < .001). Absolute humidity was significantly higher in Kendall Aerodyne 2000
compared to MR850, regardless of the selected temperature and flow (P < .001).
CONCLUSIONS:
This new method of Boussignac CPAP humidification yielded humidity values above 25 mg H2O/L
regardless of the heated humidifier and flow used. Pressurization values remained constant in each
experimental situation and were not influenced by adding humidification. These data open up the
possibility of using Boussignac CPAP on different types of patients, with different interfaces and for
long periods of time.
KEYWORDS:
Boussignac, CPAP, active humidification, acute respiratory failure, noninvasive ventilation

2-Boussignac continuous positive airway pressure device in
the emergency care of acute cardiogenic pulmonary oedema:
a randomized pilot study.
Moritz F, Benichou J, Vanheste M, Richard JC, Line S, Hellot MF, Bonmarchand G, Muller
JM.
Author information
Abstract
This study aimed to assess the short-term respiratory effects of a new portable device that delivers
a continuous positive airway pressure via a face mask (Boussignac-CPAP) in patients with severe
acute cardiogenic pulmonary oedema, and the feasibility of using this technique in an emergency
department. We prospectively studied 30 consecutive patients with acute cardiogenic pulmonary
oedema. They were randomly assigned either to the Boussignac-CPAP valve, which delivered
oxygen, or to standard oxygen delivery for a duration of 30 min. The end-expiratory pressure
reached 9.3+/-0.3 cm H2O with the Boussignac-CPAP valve. At the end of the 30 min period, the
decreases in respiratory rate and muscular activity were significantly greater among patients
assigned to the Boussignac-CPAP valve compared with those on standard oxygen delivery [24+/-
1.6 breaths/min, median 24 (15-37) versus 28.5+/-1.9, median 27 (16-38) and 1.3+/-0.2, median 1
(0-4) versus 2.7+/-0.3, median 2 (0-4), respectively]. Moreover, the arterial oxygen tension to
inspired oxygen concentration ratio and tidal volume were improved at the end of the 30 min
Boussignac-CPAP period compared with baseline. Boussignac-CPAP was easily implemented and
no side-effects were reported. Continuous positive pressure delivered using the Boussignac-CPAP
device is feasible in an emergency care setting. It can quickly improve respiratory distress in acute
cardiogenic pulmonary oedema patients. A larger trial should be initiated in such an emergency
care setting to demonstrate the effectiveness of the Boussignac-CPAP device.

3-[Laboratory testing measurement of FIO2 delivered by
Boussignac CPAP system with an input of 100% oxygen].
[Article in French]
Templier F, Dolveck F, Baer M, Chauvin M, Fletcher D.
Author information
Abstract
INTRODUCTION:
CPAP (Continuous Positive Airway Pressure) is one of the treatments of the cardiogenic acute
pulmonary edema (cAPE). Among the out-of-hospital used devices, Boussignac CPAP (Vygon)
shows a good technical usability, but no analysis of delivered FIO2 is available.
OBJECTIVE:
To measure the FIO2 delivered to patient, using Boussignac CPAP with an input of 100 vol %
oxygen. Type of study. - Measurement in a laboratory testing.
MATERIAL AND METHOD:
Measurement of delivered FIO2 in a three parameters environment: expiratory positive airway
pressure (EPAP), respiratory rate (RR) and required oxygen flow (ROF). Laboratory test: 100 vol %
oxygen input, with a ball-type flow regulator for oxygen 0-30 l x min(-1) (Mediline), Boussignac
CPAP valve with manometer (Vygon), Michigan test lung, ventilator Csar (Taema), oxygen
analysis (Servomex) with paramagnetic sensor, with a response time < 10 s, pneumotachographe
(Fleisch v 2).
RESULTS:
Under 10 cmH2O EPAP, the required oxygen flow is < or = 30 l x min(-1). Measured FIO2 ranges
from 70 to 100 vol %, for a volume per minute < or = 15 l x min(-1) except for a EPAP at 2.5 cmH2O
with a rate = 10 c min(-1) and a tidal volume (VT) at 1500 ml where the measured FIO2 is 60 vol %.
For a volume per minute > 15 l x min(-1) and < 20 l x min(-1), measured FIO2 ranges from 59 to 83
vol % depending on the variations of RR and VT.
CONCLUSION:
Boussignac CPAP with 100 vol % oxygen input, delivers high levels of FIO2, especially for volume
per minute values usually met in cAPE. The needed oxygen flow is lower than what is usually
required by other CPAP flow generators using the venturi effect that may be used in out-of-hospital
medical care.

4-Boussignac CPAP in the postoperative period in morbidly
obese patients.
Gaszynski T, Tokarz A, Piotrowski D, Machala W.
Author information
Abstract
BACKGROUND:
In the postoperative period hypoventilation and hypoxia with hypercarbia may occur in morbidly
obese patients due to the residual influence of general anesthesia drugs, postoperative atelectasis
and postoperative pain. Non-Invasive Ventilation (NIV) is a method of improvement of respiratory
efficiency in patients not requiring mechanical ventilation. The aim of the study was to compare NIV
(Boussignac) CPAP and traditional oxygen delivery via nasal catheter in the postoperative acute
care unit (PACU) in morbidly obese patients after open Roux-en-Y gastric bypass (RYGBP).
METHODS:
19 morbidly obese patients scheduled for elective open RYGBP, were randomly divided into 2
groups: CPAP (10 patients) or control (nasal catheter - 9 patients). Patients consisted of: 8 male
and 11 female, mean weight 127.76 +/- 18.5 kg, height 173.41 +/- 9.41 cm, BMI 42.43 +/- 3.3
kg/m2, age 35.84 +/- 9.05 years. In the PACU, capillary blood gas measurements were taken at 3
Time Points: T1 - 30 min, T2 - 4 hours and T3 - 8 hours after admission. Sample T0 was taken
before surgery. For management of postoperative pain, patients received morphine 2 mg/h
intravenously and tramadol 100 mg.
RESULTS:
Mean blood gas measurements of all postoperative time points were: pO2 81.0+/-16.0 (range 78.1-
85.7) mmHg vs 65.9+/-4.9 (range 63.8-68.1) mmHg (P<0.05); pCO2 40.6+/-2.4 (range 39.4-41.8)
mmHg vs 41.5+/-4.0 (range 39.6-43.4) mmHg (P>0.05), in the CPAP and control groups
respectively. In every case, pulse-oxymetry oxygenation was >94%.
CONCLUSION:
Boussignac CPAP improved blood oxygenation compared to passive oxygenation with a nasal
catheter but had no influence on CO2 elimination in non-CO2 retaining morbidly obese patients.

5-Continuous positive airway pressure via the Boussignac
system immediately after extubation improves lung function
in morbidly obese patients with obstructive sleep apnea
undergoing laparoscopic bariatric surgery.
Neligan PJ, Malhotra G, Fraser M, Williams N, Greenblatt EP, Cereda M, Ochroch EA.
Author information
Abstract
BACKGROUND:
Morbidly obese patients are at elevated risk of perioperative pulmonary complications, including
airway obstruction and atelectasis. Continuous positive airway pressure may improve postoperative
lung mechanics and reduce postoperative complications in patients undergoing abdominal surgery.
METHODS:
Forty morbidly obese patients with known obstructive sleep apnea undergoing laproscopic bariatric
surgery with standardized anesthesia care were randomly assigned to receive continuous positive
airway pressure via the Boussignac system immediately after extubation (Boussignac group) or
supplemental oxygen (standard care group). All subjects had continuous positive airway pressure
initiated 30 min after extubation in the postanesthesia care unit via identical noninvasive ventilators.
The primary outcome was the relative reduction in forced vital capacity from baseline to 24 h after
extubation.
RESULTS:
Forty patients were enrolled into the study, 20 into each group. There were no significant
differences in baseline characteristics between the groups. The intervention predicted less
reduction in all measured lung functions: forced expiratory volume in 1 s (coefficient 0.37, SE 0.13,
P = 0.003, CI 0.13-0.62), forced vital capacity (coefficient 0.39, SE 0.14, P = 0.006, CI 0.11-0.66),
and peak expiratory flow rate (coefficient 0.82, SE 0.31, P = 0.008, CI 0.21-0.1.4).
CONCLUSIONS:
Administration of continuous positive airway pressure immediately after extubation maintains
spirometric lung function at 24 h after laparoscopic bariatric surgery better than continuous positive
airway pressure started in the postanesthesia care unit.

6-Effects Of Boussignac CPAP Mask Vs
Venturi Mask On Postoperative Gas
Exchange After Lung Resection
Luis Puente-Maestu , MD,PhD
1
, Ignacio Garutti , MD
2
, Paula
Rodriguez , MD
3
, Liliana Moran , MD
3
, Juan Laso , MD
2
, Raul Sevilla , MD
2
,
Publication Date: 2013



Read More: http://www.atsjournals.org/doi/abs/10.1164/ajrccm-
conference.2013.187.1_MeetingAbstracts.A5723

7- Role of the Boussignac Continuous Positive
Pressure Mask in
the Emergency Department

Eisenman A MDa,b, Rusetski V MDa
, Sharivker D MDa
, Avital RN MAa



a Department of Emergency Medicine, Western Galilee Hospital, Naharia, Israel b Rappaport
Faculty of Medicine, Israel Institute of TechnologyTechnion, Haifa, Israel





Abstract


Objectives: (1) To determine whether noninvasive continuous positive airway pressure (CPAP)
ventilation
with the Boussignac face mask can reverse acute respiratory failure in patients with congestive
heart failure
(CHF) or chronic obstructive pulmonary disease (COPD) in the emergency department (ED); (2) To
characterize patients who may benefit from this method.
Methods: Patients presenting to the ED in 2004 with respiratory distress, who were referred for
mechanical
ventilation, were first allocated to a treatment trial with Boussignac-CPAP. Success was defined as
an
improvement in respiratory parameters without subsequent need for endotracheal intubation.
Data were
collected on demographic and clinical features, diagnosis and respiratory parameters, door-to-
treatment
interval, and outcome.
Results: The sample included 86 patients of average age 74.3 years. The main indications for CPAP
ventilation were CHF (78%), diagnosed mainly by chest x-ray, and COPD (54.6%), diagnosed mainly
by
physical examination. The large majority of patients were conscious (90.7%) and fully cooperative
(83%).
Average time from admission to ventilation was 16+22 minutes. Respiratory parameters improved
in 80
patients (93%); the major improvement occurred within the first 30 minutes of treatment. Only 6
patients
(7%) subsequently required full ventilation. Sixty-nine patients (91%) were admitted to general
medical
wards and 7 (9%) to the intensive care unit; the remainder were discharged home.
Conclusions: Noninvasive CPAP via the Boussignac face mask is a near-ideal means of ventilation in
the
ED, provided patients are carefully selected. It improves respiratory distress in most patients; is
associated
with very few side effects; and spares patients full mechanical ventilation.

pag web:
http://isrjem.org/Isrjem_June08.CPAP%20Eisenman_Postprod.pdf

8-The usage of the Boussignac continuous positive airway pressure system in acute
respiratory failure
Wong D. T.
1
, Tam A. D.
2
, Van Zundert T. C. R. V.
3

1
Department of Anesthesia, Toronto Western Hospital, University of Toronto, ON, Canada;
2
College of Biological Science, University of Guelph, ON, Canada;
3
Department of Anesthesia, Maastricht University Medical Centre, Maastricht, The Netherlands
Traditionally, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP)
devices have been used to treat patients in acute respiratory failure. However they require an electric
power source, are relatively large in size, and may be difficult to use in prehospital settings. The
recently introduced Boussignac CPAP system is capable of delivering 10 cmH2O of CPAP, is compact,
portable and requires only an oxygen source. This paper reviews the efficacy of using Boussignac
CPAP as a treatment for acute respiratory failure in both prehospital and hospital settings. All studies
mainly focused on patients treated for cardiogenic pulmonary edema. In the prehospital setting,
Boussigac CPAP significantly improved respiratory parameters and oxygenation from baseline values.
In the emergency department setting, Boussignac CPAP was more effective than standard oxygen
delivery and just as effective as BiPAP in improving patient oxygenation and respiration. In one study,
implementing Boussignac CPAP reduced intubation rate and hospital stay. Most hospital staff found
Boussignac CPAP easy to use and complication rates were low. Boussigac CPAP is a useful device in
the treatment of patients with acute respiratory failure, especially in the prehospital setting.
lingua: Inglese

pagian web:
http://www.minervamedica.it/it/riviste/minerva-
anestesiologica/articolo.php?cod=R02Y2013N05A0564

9-Practical use, effects and complications
of prehospital treatment of acute
cardiogenic pulmonary edema using the
Boussignac CPAP system
Eva Eiske Spijker12
*
, Maarten de Bont3, Matthijs Bax4 and Maro Sandel5


10- CPAP de Boussignac en procedimientos
diagnstico-teraputicos
en pacientes crticos -scielo-
.


Bing:

1- La CPAP de Boussignac preserva la
funcin pulmonar tras la ciruga
baritrica laparoscpica
2-3 guias para el uso en urgencias y emergencias
4- protocolo de bolsillo
5- CPAP BOUSSIGNAC: PROTOCOLO DE
ACTUACION Y CUIDADOS DE ENFERMERIA
6- Vlvula de Boussignac y CPAP frente a diferentes situaciones de
temperatura y humedad ambiental Resumen
INTRODUCCIN. La vlvula de Boussigna permite entregar un nivel de presin positiva continua en
va area (CPAP) a los enfermos, con la nica necesidad de una fuente de gas de alto flujo.
Estudiamos si las variaciones en la humedad y temperatura podran afectar al dispositivo de CPAP.
MATERIAL Y MTODO. Estudio experimental, realizado en condiciones de laboratorio. Medimos la
CPAP conseguida mediante una vlvula de Boussignac de Vygon ante distintas condiciones de
humedad y temperatura ambiental. Se utilizaron, adems de la citada vlvula, una fuente de O2
medicinal con un caudalmetro, un serpentn de cobre para calentar/enfriar el gas, un humidificador
Respiflo de Kendall, y una cubeta de aislamiento trmico. Las mediciones de CPAP se hicieron con
un manmetro digital, y las de temperatura y humedad con un termo-higrmetro (previamente
calibrados). Tras realizar varias mediciones para un mismo flujo, ante distintas condiciones de
humedad y temperatura, se compararon los resultados obtenidos mediante la prueba de la "t" de
Student (comparaciones dos a dos) y ANOVA. Se demand un intervalo de confianza mnimo de 95%.
RESULTADOS. Para los diferentes flujos analizados (15, 20 y 25 litros/minuto) se comprueba cmo
ante distintas condiciones de temperatura (en rangos de 4-6 C, 24-26 C y 40-42 C) y humedad (2%,
15-20%, 35-40% y 80-85%) se obtienen diferencias estadsticamente significativas en los niveles de
CPAP entregados. CONCLUSIN. La temperatura y la humedad a la que se utilicen el oxgeno y el
dispositivo de CPAP de Boussignac influyen en los niveles de presin obtenidos, pudiendo llegar a
diferencias de presin cercanas al 20% en algunas circunstancias, para un mismo flujo.
7- CPAP DE BOUSSIGNAC EN URGENCIAS.
Eva Lista Arias, Javier Jacob Rodrguez, Xavier Palom Rico, Gilberto Alonso Fernndez


RESUMEN


Sr. Director hemos ledo con inters la revisin de JM. Carratala y J. Masip, La
ventilacin no invasiva en la insuficiencia cardiaca aguda: uso de CPAP en los servicios de
urgencias
1
, sabiendo que es una tcnica poco utilizada en urgencias
2
, en
nuestro hospitalpusimos en marcha un proyecto para usarla ms, concretamente
la CPAP de Boussignac, al ser un sistema fcil, verstil y barato de aplicacin de presin
positiva en el edema agudo de pulmn hipoxmico. Nuestra experiencia es de 10 casos, 8
mujeres y 2 hombres, con una edad media de 79.8 aos, la mejora de la disnea fue del
100%, trabajo respiratorio (escala de Patrick) del 100%, remisin total del 70% y
saturacin > 95% en todos los casos. Ningn caso preciso de IOT, la mortalidad fue nula, la
duracin de la CPAP fue de 3.63 horas, no hemos tenido ningn caso en que hayamos
tenido que prolongarla, pues la aplicacin del resto de medidas teraputicas han sido
eficaces
3
. Hemos acortado la duracin en 2 casos por claustrofobia, siendo inferior a 30
minutos. Deducimos que el sistema Boussignac es un buen sistema de presin positiva,
pero no nos permiten una precisin de la aportacin de la presin, por lo tanto, subir o bajar
de 2 en 2 cm de H2O no es muy aplicable. Los valores de presin aportados oscilan entre 7
y 10, guiados mayoritariamente por la saturacin arterial de oxgeno (variable inmediata)
ms que por el trabajo respiratorio (variable ms tarda). Tampoco permite la deteccin,
medida o correccin de la fuga, nicamente el manmetro nos indica la demanda de presin
inspiratoria del paciente y nosotros debemos interpretar si es por fuga o por fatiga
inspiratoria, por lo que aceptamos una variabilidad de 2 cm de H2O; de acuerdo con los
autores, los sistemas de CPAP no pueden considerarse propiamente sistemas de ventilacin,
por lo que la fuga es un elemento perdido en estas situaciones.
En el manejo del edema pulmonar que cursa con hipercapnia, estamos de acuerdo en
emplear el doble nivel de presin, siendo fundamental el control de la fuga
4
. Pensamos que
aportar una FIO2 mxima, del 100% segn los autores, en el sndrome hipercpnico no es
apropiado, y menos an cuando podemos optimizar la saturacin de oxgeno con la presin
espiratoria, es ms, este parmetro debera ser el ltimo en manipularse en situaciones de
hipercapnia.
1. Carratala JM, Masip J. Ventilacin no invasiva en la insuficiencia cardiaca aguda: uso
de CPAP en los servicios de urgencias. Emergencias 2010; 22: 49-55.
2. LLorens P et al. Perfil clnico de los pacientes con Insuficiencia Cardiaca en los
Servicios de Urgencias: Datos preliminares del estudio EAHFE (Epidemiology Acute Heart
Failure Emergency). Emergencias 2008;20:154-63.
3. Carballo Cardona C, Moreno Zabaleta R, Moreno Planelles MD. Ventilacin no
invasiva en los servicios de urgencias. Revista Iberoamericana de Ventilacin Mecnica no
Invasiva 2009; 13:32-39.
4. Ayuso Baptista F, Jimnez Moral G, Fonseca del Pozo. Manejo de la insuficiencia
respiratoria aguda con ventilacin mecnica no invasiva en urgencias y emergencias.
Emergencias 2009; 21:189-20
8- Ttulo:
CPAP de Boussignac en procedimientos diagnstico-teraputicos en pacientes crticos
Claves:
CPAP Boussignac
Fibrobroncoscopia
Endoscopia
Hemorragia digestiva
Insuficiencia respiratoria aguda
Edema agudo de pulmn
D
e
s
c
r
i
p
c
i

n
:
La vlvula de Boussignac se ha convertido en un elemento a tener en cuenta en el manejo el edema agudo
de pulmn. Gracias a su capacidad para generar presin positiva continua en la va area (CPAP) y su
simplicidad, su utilizacin se est extendiendo en los servicios de emergencias y de urgencias y las plantas
de hospitalizacin. Consiste en un pequeo tubo que se coloca sobre el puerto espiratorio de la mascarilla.
El flujo (oxgeno/aire) se acelera al pasar a travs de cuatro microcanales que existen en la pared de la
vlvula, y por el principio de la energa en movimiento, consiguen presurizar el rbol bronquial. Su sistema
de funcionamiento, no hermtico, permite el paso de una sonda a travs de ella para asistir al paciente
(beber, alimentarse, aspirar, etc.). Ello la capacita para ampliar su utilizacin en pacientes que, estando en
situacin lmite, necesitan pruebas diagnsticas que pudieran empeorar la situacin respiratoria, como los
procedimientos endoscpicos. Presentamos a 3 pacientes crticos a los que se administr CPAP con una
vlvula de Boussignac acoplada a una mascarilla orofacial durante la realizacin de dos fibrobroncoscopias
y una endoscopia digestiva alta. Los 3 casos culminaron con xito y no se necesit la intubacin
orotraqueal.
9- Utilizacin de la CPAP de Boussignac en la Sedacin en
endoscopia
Autores: Francisca Gmez Garca, Luis Margaix Margaix, Rosa Zaragoza Gradoli, Amparo Rubio Valverde
Localizacin: Enfermera integral: Revista cientfica del Colegio Oficial de A.T.S de Valencia, ISSN 0214-
0128, N. 90, 2010 , pgs. 33-36

o Texto Completo Ejemplar
Resumen
o El desarrollo de la endoscopia en los ltimos aos ha trado como consecuencia una gran variedad de
procedimientos diagnsticos y teraputicos, que pueden resultar incmodos y dolorosos para el paciente .El
papel del anestesilogo en estas situaciones es muy importante para garantizar la confortabilidad y la
seguridad del paciente.
La CPRE (colangiopancreatografi a retrograda endoscopia) es una tcnica muy molesta ya que hay que
invertir normalmente mucho tiempo en ella, y adems es muy importante mantener al paciente inmvil. Por
ste motivo, la realizamos siempre con sedacin profunda, ya que se reconoce que el disconfort, la
inmovilidad y la duracin de la CPRE disminuyen la tolerancia y condicionan el xito del procedimiento. Es
sobre todo en stos casos cuando comenzamos a utilizar la CPAP, ya que observamos junto con los
anestesistas que mejoraba la oxigenacin del paciente.
La CPAP de Boussignac es un dispositivo no mecnico de Ventilacin no Invasiva, cilndrico, hueco y ligero
(slo 6.5 gr.) de 5,6 cm. de largo por 2,2 cm. de dimetro que se conecta a una mascarilla facial por su
extremo proximal (racor macho), quedando el extremo distal (dentado) abierto al exterior.
La CPAP de Boussignac aplica una presin positiva constante en la va area del paciente mientras ste
respira espontneamente; dicha presin se mantienen en un valor superior al atmosfrico en todo el ciclo
respiratorio.
La Presin Positiva Continua en la Va Area-Continuos Positive Airway Presure- o CPAP es un modo
ventilatorio que pretende la optimizacin de la ventilacin del paciente en situacin de hipoxemia y es
utilizable sin invadir su va area.

copyscape: se dedica a encontrar sitios que han citado contenido sin autorizacion.
cuil:
1- CPAP BOUSSIGNAC: PROTOCOLO DE ACTUACION
Y CUIDADOS DE ENFERMERIA
2- GUA PARA EL USO DEL
CPAP BOUSSIGNAC

SERVICIO DE URGENCIAS
HOSPITAL SAN PEDRO - LOGROO
3- Boussignac CPAP in acute respiratory failure
Federico Lari, Francesco Savelli, Fabrizio Giostra, Gianpaolo Bragagni, Nicola Di Battista

Abstract

Introduction: The application of continuous positive airway pressure (CPAP) is one of the most
important therapeutic interventions used in patients with acute respiratory failure (ARF) secondary
to acute cardiogenic pulmonary edema (ACPE). Thanks to its positive effects on both
hemodynamics and ventilation, CPAP improves clinical and blood-gas parameters. Compared with
standard oxygen therapy, use of CPAP is associated with decreased mortality and reduced need
for intubation in these patients.
Aim of the study: This review examines the principles of CPAP, techniques and equipment used to
deliver it, and clinical applications. Special emphasis is placed on CPAP delivered with the
Boussignac device.
Discussion and conclusions: In emergency departments, this simple, lightweight, disposable device
has proved to be well tolerated and similar to Venturi-like flow generators in terms of effectiveness.
These findings suggest that Boussignac CPAP might be useful for managing ARF in non-critical
care areas where other more complicated CPAP equipment (Venturi-like flow generators and
ventilators) are not available (for example, in general medical wards).

4- Boussignac CPAP in the postoperative period in morbidly
obese patients.
Gaszynski T, Tokarz A, Piotrowski D, Machala W.
Author information
Abstract
BACKGROUND:
In the postoperative period hypoventilation and hypoxia with hypercarbia may occur in morbidly
obese patients due to the residual influence of general anesthesia drugs, postoperative atelectasis
and postoperative pain. Non-Invasive Ventilation (NIV) is a method of improvement of respiratory
efficiency in patients not requiring mechanical ventilation. The aim of the study was to compare NIV
(Boussignac) CPAP and traditional oxygen delivery via nasal catheter in the postoperative acute
care unit (PACU) in morbidly obese patients after open Roux-en-Y gastric bypass (RYGBP).


5- Vlvula de Boussignac y CPAP
frente a diferentes situaciones de
temperatura y humedad ambiental

6- [Laboratory testing measurement of FIO2 delivered by
Boussignac CPAP system with an input of 100% oxygen].

7- Use of the Boussignac CPAP System Immediately Following
Extubation to Improve Lung Function in Adults With Moderate to
Severe Obstructive Sleep Apnea
pagina web:
http://clinicaltrials.gov/show/NCT01877928

8- Vlvula de Boussignac y CPAP frente a diferentes situaciones
de temperatura y humedad ambiental (dialnet)

9- Article
[Laboratory testing measurement of FIO2 delivered by Boussignac
CPAP system with an input of 100% oxygen].
F Templier, F Dolveck, M Baer, M Chauvin, D Fletcher
Samu 92-Smur Garches, hpital Raymond-Poincar, 104, boulevard Raymond-Poincar, 92380, Garches,
France.
Annales Franaises d Anesthsie et de Ranimation (Impact Factor: 0.84). 02/2003; 22(2):103-7.
Source: PubMed
ABSTRACT CPAP (Continuous Positive Airway Pressure) is one of the treatments of the cardiogenic acute
pulmonary edema (cAPE). Among the out-of-hospital used devices, Boussignac CPAP (Vygon) shows a good
technical usability, but no analysis of delivered FIO2 is available.
To measure the FIO2 delivered to patient, using Boussignac CPAP with an input of 100 vol % oxygen. Type of
study. - Measurement in a laboratory testing.
Measurement of delivered FIO2 in a three parameters environment: expiratory positiveairway pressure
(EPAP), respiratory rate (RR) and required oxygen flow (ROF). Laboratory test: 100 vol % oxygen input, with a
ball-type flow regulator for oxygen 0-30 l x min(-1) (Mediline), Boussignac CPAP valve with manometer
(Vygon), Michigan test lung, ventilator Csar (Taema), oxygen analysis (Servomex) with paramagnetic sensor,
with a response time < 10 s, pneumotachographe (Fleisch v 2).
Under 10 cmH2O EPAP, the required oxygen flow is < or = 30 l x min(-1). Measured FIO2 ranges from 70 to
100 vol %, for a volume per minute < or = 15 l x min(-1) except for a EPAP at 2.5 cmH2O with a rate = 10 c
min(-1) and a tidal volume (VT) at 1500 ml where the measured FIO2 is 60 vol %. For a volume per minute >
15 l x min(-1) and < 20 l x min(-1), measured FIO2 ranges from 59 to 83 vol % depending on the variations of
RR and VT.
Boussignac CPAP with 100 vol % oxygen input, delivers high levels of FIO2, especially for volume per minute
values usually met in cAPE. The needed oxygen flow is lower than what is usually required by other CPAP flow
generators using the venturi effect that may be used in out-of-hospital medical care.
10- Pneumatic Performance of the Boussignac
CPAP System in Healthy Humans
Maria Sehlin RPT MSc, Siv Sandkvist To rnell MD, Fredrik O hberg PhD,
Go ran Johansson MSc, and Ola Winso MD PhD

11- CPAP-valve (Boussignac) during Resuscitation
Track this topic | Email this topic | Print this topic
svanhooreweghe
Posted: Jul 6 2005, 09:48 AM






Group:
Full Member

Posts: 5
Member No.: 1411
Joined: 1-October 02



As I saw a representative yesterday who very nicely tried te convince
me of the benefits of the boussignac CPAP endotracheal tube (Vygon)
in reanimation, I would like to know if anybody has experience with
this device.
As perfusion pressure only builds up very slowely the trend is to
augment the amount of cardiac compressions before interruption by
insufflation. We now are on 15:2.
With this Boussignac-tube the lungs are slightly insufflated
spontaneously after every compression, due to the small amount of
PEEP, hence cardiac compressions would not anymore have to be
interrupted by insufflation.
Is this gods way to show how much he likes us, or is this just
another hype?

12- The Practitioner
Le practicien
The occasional acute application of
continuous positive airway pressure

13- Active Humidification With
Boussignac CPAP: In Vitro Study of a
New Method

14- Use of the Boussignac CPAP System Immediately Following
Extubation to Improve Lung Function in Adults With Moderate to
Severe Obstructive Sleep Apnea

15- BOUSSIGNAC PRESENTA LAS NOVEDADES EN REANIMACIN CARDIOVASCULAR
El General de Alicante actualiza la formacin en
ventilacin no invasiva en Urgencias

Redaccin. Alicante
El Servicio de Emergencias Sanitarias (SES) de Alicante ha organizado, con la colaboracin
de la Sociedad Cientfica de Urgencias y Emergencias Autonmica y Nacional, la Jornada
de Actualizacin en Ventilacin No Invasiva (VMNI) en Urgencias-Emergencias", as como
un encuentro con el doctor Georges Boussignac.
Este especialista, que se encuentra entre los
ponentes expertos tanto a nivel autonmico como nacional, es pionero en VMNI a nivel
mundial y ha presentado las novedades actuales en reanimacin cardiopulmonar.
Esta jornada cuenta con un foro de ms de 300 personas inscritas, entre los que se
encuentran directivos de los servicios de Emergencias de otras comunidades autnomas,
as como diversos jefes de Servicio de Urgencias Hospitalarios.
Mercedes Carrasco, directora del SES-Alicante, ha destacado el repaso que se hace de las
indicaciones y beneficios de la VMNI y de los registros que ya se han realizado a nivel
nacional. Tambin se han presentado las novedades en reanimacin cardiopulmonar
Sistema Cpap Boussignac
La ventilacion no invasiva (VMNI) y su aplicacin con la CPAP de Boussignac representan
"un espectacular avance en el tratamiento inicial en los pacientes aquejados de fracaso
respiratorio agudo", segn explican los especialistas, e incide directamente en grandes
beneficios para los enfermos, ya que disminuye la morbi-mortalidad al reducir la
necesidad de intubacin orotraqueal y conexin a ventilacin mecnica. Adems, acorta la
estancia en los Servicios de Medicina Intensiva. Su aplicacin precoz en el mbito
prehospitalario est garantizando estos resultados.
web: http://cardiologia.publicacionmedica.com/spip.php?article412


15- Effects Of Boussignac CPAP Mask Vs
Venturi Mask On Postoperative Gas
Exchange After Lung Resection
Luis Puente-Maestu , MD,PhD
1
, Ignacio Garutti , MD
2
, Paula
Rodriguez , MD
3
, Liliana Moran , MD
3
, Juan Laso , MD
2
, Raul Sevilla , MD
2
,
Publication Date: 2013



Read More: http://www.atsjournals.org/doi/abs/10.1164/ajrccm-
conference.2013.187.1_MeetingAbstracts.A5723

16- Manejo de la insuficiencia respiratoria aguda
con ventilacin mecnica no invasiva en urgencias
y emergencias
FERNANDO AYUSO BAPTISTA1
, GABRIEL JIMNEZ MORAL2
, FRANCISCO JAVIER FONSECA DEL POZO3

exalead: me aparece 0 resultados

duckduckgo: seguir....
1- https://duckduckgo.com/?q=cpap+boussignac